Featured Posts
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Search Posts
Op-Eds
The Harmful Side Effect We Never Hear About
Editor's note: This is the first of two articles. <?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> For the second part in this…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. CONGRESS The House Education and Labor Committee holds a hearing on changes…
Op-Eds
Heart Stents and FDA Blockage
Is it another medical breakthrough gone unexpectedly bad? The drug-eluting heart stent is under increased scrutiny because of a complication…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. CONGRESS ExxonMobil’s record profits prompt calls for a windfall profits tax on the…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. CONGRESS “Politicians love the minimum wage. It is a perfect issue on which to demagogue, since…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. ENERGY Thousands gather in Mexico City to protest steeply rising prices for…